Lutetium Lu 177 dotatate
Lutetium Lu 177 dotatate is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand names including BEXLUTRY, Lutathera. Available dosage form: injection.
Drug details
- Generic Name
- Lutetium Lu 177 dotatate
- Brand Names
- BEXLUTRY, Lutathera
- Application Number
- NDA218525
- Sponsor
- Curium US LLC
- NDC Codes
- 2
- Dosage Forms
- INJECTION
- Routes
- INTRAVENOUS
- Active Ingredients
- LUTETIUM OXODOTREOTIDE LU-177
Indications and Usage
1 INDICATIONS AND USAGE LUTATHERA is indicated for the treatment of adult and pediatric patients 12 years and older with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut, and hindgut neuroendocrine tumors. LUTATHERA is a radiolabeled somatostatin analog indicated for the treatment of adult and pediatric patients 12 years and older with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut, and hindgut neuroendocrine tumors.